DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20220156
Published: 2022-01-28

Médical interruption of pregnancy in the 2nd and 3rd trimester of pregnancy: about 42 cases collged ať the Tunis Maternity and Neonatology Center “Service A”

Nebnomyidboumbou Norbert Wenceslas Djiguemde, Timongo Francoise Danielle Millogo Traore, Jean Lankoande, Dalenda Chanouffi Cheli, Ezzidine Sfar

Abstract


Background: Study IMGs in the 2nd or 3rd trimester of pregnancy in department “A” of the CMNT.

Methods: Descriptive and analytical cross-sectional study in the “A” obstetrics gynecology department of the CMNT from January to June 2012. The variables studied related to sociodemographic characteristics, diagnosis, management and prognosis. Undiagnosed fetal abnormalities in the 1st trimester, serious maternal pathologies are the inclusion criteria. IMGs for embryofetopathies and MFIUs were not included in the study.

Results: The average age was 32 years with an average term of 27 weeks of amenorrhea and 01 day. The indication was 97.6% fetal. Fetal malformations were divided into 54.8% neurological abnormalities, 4.8% renal abnormalities, 4.8% digestive abnormalities, 4.8% bone abnormalities, 2.4% pulmonary abnormalities and 2.4% cardiac abnormalities. The foeto-pathological examination was carried out 64.3% confirming the antenatal diagnosis with an ultrasound sensitivity of 67.6% in the 2nd trimester and 83.3% in the 3rd trimester. The overall expulsion time was 30.6 hours (<28 SA) and 43.9 hours (>28 SA), an overall success rate at 24 hours of 97.6% with one uterine rupture, 3 uterine retentions and hemorrhage. No cases of maternal death or infection were observed.

Conclusions: The delay in the diagnosis of fetal pathologies makes it difficult to decide on abortion for practitioners and parents. Antenatal ultrasound and fetal karyotype represented the means that made it possible to pose or suspect the diagnosis of fetal abnormality.


Keywords


Medical interruption 2nd and 3rd trimester, Fetal malformations, Dyschromosomia, Rubella, Fetopathology, Ultrasound sensitivity, CMNT

Full Text:

PDF

References


Marret H, Perrotin F, Descamps A, Lansac J, de Magalhaes A, Body G. Interruption médicale de grossesse aux 2èmes et 3èmes trimestres. A propos de 125 indications de 1992 à 1995. J Gynecol Obstet Biol Reprod. 1999; 28:245-52.

De Vigan C, Khoshnood B, Lhomme A. Prévalence et diagnostic prénatal des malformations en population parisienne. J Gynecol Obstet Biol Reprod. 2005; 34:8-16.

Aslan H, Yildirim G, Ongutb C, Ceylan Y. Termination of pregnancy for fetal anomaly. International Journal of Gynecology and Obstetrics. 2007;99:221-4.

Dommergues M, Benachi A, Benifla JL, des Noettes R, Dumez Y. The reasons for termination of pregnancy in the third trimester. Br J Obstet Gynecol. 1999;106(4):297-303.

Escalante PD, Zapata CI, Allec RD. Spectrum of congenital malformations observed in neonates of consanguineous parents. An Pediatr (Barc). 2006;64:5-10.

Creinin MD, Schwartz JL, Guido RS, Pymay HC. Early Pregnancy Failure-Current Management Concepts. Obstetrical and Gyncological Survey. 2001;56(2):105-13.

Bonnefoy R, Poinsot J, Vaillant MC, Chantepie A. Evolution du diagnostic anténatal des cardiopathies congénitales entre 1991 et 2005 dans une population limitée au département d'Indre-et-Loire. Arch Pediatr. 2011;18:512-7.

Buskens E, Grobbee DE, Frohn-Mulder IME. Efficacy of Routine Fetal Ultrasound Screening for Congenital Heart Disease in Normal Pregnancy. Circulation. 1996;94:67-72.

Khoshnood B, de Vigan C, Vodovar V, Goujard J, Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG. 2004;111:485-90.

Peterson CC. A review of biochemical and ultrasound markers in the detection of Down’s syndrome. Journal of Perinatal Education. 2006;15:19-25.

Sfar E, Hendaoui Med S, Bitri M, Siala, Chelli H. Indications de l’interruption médicale de la grossesse (IMG) au cours des anomalies fœtales diagnostiquées in utero. Tunisie médicale. 1997;75(n°10) :750-3.

Georges Boog. Performances et limites de l'échographie obstétricale. EMC Obstétrique [5-003-A-10] Amann J-P. Diagnostic prénatal et interruption médicale de grossesse : aspects éthiques. J Pédiatr Puériculture. 2003;16:147-55.

Baalbaky I, Manouvrier S, Dufour P. Le diagnostic anténatal de l’ostéogenèse imparfaite : à propos de deux observations. J Gynecol Obstet Biol Reprod. 1998;27:44-51.

Chaabouni H, Chaabouni M, Maazoul F, M’Rad R, Jemaa L, Zouari F. Prenatal diagnosis of chromosome disorders in Tunisian population. Annales de génétique. 2001;44:99-104.

Chawdhary R, Rana A, Pradhan N. Mifepristone plus misoprostol par voie vaginale vs misoprostol par voie vaginale seule pour l'avortement médicamenteux en gestation de 63 jours ou moins dans les femmes népalaises: un quasi-randomisée et contrôlée trial. J Obstet Gynaecol Res. 2009;35(1):78-85.

Mazouni C, Provensal M, Porcu G, B Guidicelli, Heckenroth H. Misoprostol-induced termination of second trimester pregnancy in women with a history of cesarean section: A retrospective analysis of 56 cases. Ginekol Pol. 2013 ;84 :277-80.

Contraception césarienne précédente. 2006;73(3):244-8.

Ellertson C, Waldman S. The Mifepristone-Misoprostol Regimen for Early Medical Abortion. Current Women's Health Reports. 2001;1:184-90.

Letourneur B, Parant O, Tofani V, Berrebi A. Fédération de Gynécologie-Obstétrique, CHU Toulouse-La Grave, place Lange, 31052 Toulouse. Uterine rupture on unscared uterus following labor induction for 2nd trimester termination of pregnancy with oral misoprostol: conservative management. Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 2002 ;31(n°4):371-3.

Dodd JM, Crowther CA. Misoprostol contre cervagem pour l'induction du travail de mettre fin à la grossesse dans le deuxième et le troisième trimestre: une approche systématique. J Obstet Gynecol Reprod Biol. 2006;125(1):3-8.

Grandjean H, Larroque D, Levi S, and the Eurofetus team. The performance of routine ultrasonographic screening of pregnancies in the Eurofetus study. Am J Obstet Gynecol. 1999;181:446-54.

Stefos T. Routine obstetrical ultrasound at 18-22 weeks: our experience on 7 236 fetuses. J Matern Fetal Med. 1999;8:64-9.

Vos JM. Sensitive and specific screening for detection of spina bifida by echography in the second trimester; systematic review and meta-analysis Ned Tijdschr Geneeskd. 2000;144:1736-41.

Rustico MA, Benettoni A, D’Ottavio G, Fischer-Tamaro L, Conoscenti GC, Meir Y et al. Early screening for fetal cardiac anomalies by transvaginal echocardiography in an unselected population: the role of operator experience. Ultrasound ObstetGynecol. 2000;16:614-9.

Stoll C. Evaluation of the prenatal diagnosis of limb reduction deficiencies. Prenat Diagn. 2000;20:812-8.